课题基金 / 基金详情

ALbumin To Enhance Recovery after severe Acute Kidney Injury (ALTER-AKI): a multicentre randomized controlled trial.

ALbumin To Enhance Recovery after severe Acute Kidney Injury (ALTER-AKI): a multicentre randomized controlled trial.
白蛋白促进严重急性肾损伤后的恢复 (ALTER-AKI)：一项多中心随机对照试验。
批准号：
489100
负责人：
Clark Edward G
金额：
$69.66万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2026-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489100&lang=en
关键词：
Acute Kidney Injury Critical Illness Dialysis Hemodynamic Instability Related To Renal Replacement Therapy Intradialytic Hypotension Intravenous Albumin Multicentre Randomized Controlled Trial Renal Replacement Therapy Ultrafiltration

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A sudden decline in kidney function, called Acute Kidney Injury (AKI), is a common complication of critical illness. For patients with severe AKI, blood-cleaning dialysis treatments prevent death from kidney failure but do not heal the kidneys. In fact, d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金